The healthcare market research themes for 2014
April 2, 2015 |
As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.
In the US, we have, and will continue to have, the shakedown from the implementation of the Affordable Care Act (aka Obamacare): the teething problems and the confusion, and gradually, so we hope, a clearer picture of what it means for physicians, insurers and patients – and for the industry as a whole. In the UK, we are looking at the implications of an independent Scotland following a referendum which will take place in September. For healthcare, there are some big questions – how would cross-Border healthcare work? Would the Scottish Intercollegiate Guidelines Network (SIGN) continue to work with NICE? And in parts of Europe, particularly France, data protection laws covering market research are making some of these markets challenging to conduct studies in. Globally, the pharma industry is under increasing scrutiny to demonstrate transparent practices and legal compliance. This requirement transfers to market research suppliers such as Research Partnership, and we need to ensure we are adhering to industry guidelines and clients’ policies with regards to project management processes.
In quantitative research, we are continuing to see a trend towards respondents completing online interviews on smartphones or tablet devices. Questionnaire design and programming is starting to take this into account – it’s very difficult to complete long batteries of rating statements on a tablet simply because the selection options can be so close together. (Hitting the wrong one by accident is sometimes referred to as ‘fat-finger syndrome’!). Online or App surveys specifically designed for smartphone or tablet devices (like our ConferenceLIVE orRxRationale services), are programmed for the device so they are built with the respondent in mind.
We are also witnessing the introduction of other gamification ideas – like giving respondents a time-limit in which to answer spontaneous questions, where the aim is to understand the top-of-mind response, or using icons to replace dry number-rating scales, a range of smiling to frowning faces to indicate satisfaction or dissatisfaction or star ratings. All these tools are designed to make the whole interview experience that bit more engaging, and encourage our respondents to consider their answers.
Beyond individual pieces of research, the role of online communities of patients or physicians and ‘scraping’ the vast wealth of pre-existing information on the internet (an example of so-called Big Data) are being explored and developed. This isn’t just about counting the number of hits or searches but about identifying and analysing relevant communications and conversations in order to gain insight into the language being used, the information needs as well as resulting behaviour.
In qualitative research, observation techniques continue to be a trend. As a society, we are becoming more open than ever to sharing information about our daily lives. Qualitative research can benefit from this by using digital, video and face-to-face techniques to garner “uncontaminated” insights from respondents, without the intrusion of a moderator, and gain valuable information about how healthcare stakeholders interact in the real world.
Exciting times to be in healthcare market research. We hold aloft our cooling glass of Pimms and look forward to the summer ahead!
Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1K6nhJ3
This content was provided by Research Partnership
Company Details
Latest Content from Research Partnership
Will gene therapies finally be commercially viable to pharma?
Our latest Free Thinking white paper explores the science behind the idea of gene therapy and takes a look at some of the core challenges medical researchers have faced when...
Wargaming in HCV
The challenge:Our client had a product ready for launch in the HCV landscape. A number of new competitor products were expected to alter the market dynamics. Given the stage of...
Living with Lupus: Breaking the Silence
Published in eyeforpharma July 2017 by Mariel Metcalfe
Demystifying human-centred design: the application of iterative, human-centric approaches in global health market research
One of the biggest buzz topics in the global health community over the last couple of years has been human-centred design, also referred to as behaviour-centred design. In this blog...
In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
The UK’s Department for International Development (DfID) was established in 1997 with a mandate to tackle world poverty. Since its inception, it has played a major role in the global...
EphMRA 2017 round up
We were delighted to present, exhibit and sponsor this year’s EphMRA Annual Conference in Amsterdam, Netherlands.
Taking a hybrid qualitative-quantitative approach to research
Directors Phil Rosenberg and Chris Gaj discuss ways to achieve qualitative insights with quantitative precision and the benefits of a hybrid approach.Watch the video: https://www.researchpartnership.com/news/2017/06/video-taking-a-hybrid-qualitative-quantitative-appr...
20th anniversary celebrations
We recently celebrated our 20th year anniversary with parties for our employees across the globe.Find out more and view the photos https://www.researchpartnership.com/news/2017/06/20th-anniversary-party-photos/
Pharma CI Asia Conference & Exhibition 2017
13-14 July 2017, Singapore
Director Richard Head is joint winner of the 2017 EphMRA President’s Award
We are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President's Award for his contribution to pharmaceutical market research